SCHEMBL16628739

SCHEMBL16628739

CCNC(=O)c1ccc2nc(N)nc(C(=O)N(CC)CC)c2c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 1/20 0.44
ASIC3 Q9UHC3 1/20 0.44
PDE2A O00408 2/20 0.43
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
LMNA P02545 1/20 0.42
MCHR1 Q99705 1/20 0.42
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
DHFR P00374 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
ACSS2 Q9NR19 1/20 0.39
ADORA3 P0DMS8 2/20 0.39
HSP90AB1 P08238 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087758 0.88 ASIC3 (0.45) ASIC3ALDH1A1HPGDMCHR1MAPT
SCHEMBL3088463 0.80 HSP90AA1 (0.53) ALDH1A1HPGDLMNAHSP90AA1MAPT
SCHEMBL16628707 0.80 TLR8 (0.39) ASIC3ALDH1A1HPGDLMNAMCHR1
SCHEMBL3092345 0.79 ALDH1A1 (0.41) ALDH1A1HPGDLMNAMAPTDHFR
SCHEMBL3087968 0.79 HSP90AA1 (0.47) ALDH1A1HPGDLMNAHSP90AA1MAPT
SCHEMBL13144829 0.79 ALDH1A1 (0.41) ALDH1A1HPGDLMNAHSP90AA1DHFR
SCHEMBL3088521 0.79 HSP90AB1 (0.45) ALDH1A1HPGDLMNAMAPTKDM4E
SCHEMBL3087756 0.79 HPGD (0.43) ALDH1A1HPGDLMNADHFRKDM4E
SCHEMBL3099210 0.79 ADORA3 (0.54) ALDH1A1HPGDLMNAHSP90AA1MAPT
SCHEMBL3085150 0.78 HSP90AA1 (0.61) ALDH1A1HPGDLMNAHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed